Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
NEW YORK and SHANGHAI, March 7, 2011 /PRNewswire-Asia/ -- Bristol-Myers Squibb Company (NYSE: BMY) and WuXi PharmaTech (NYSE: WX) today announced that they have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to support global marketing applicatio...
WuXi PharmaTech Schedules Fourth-Quarter 2010 Earnings Release
SHANGHAI, March 1, 2011 / PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quarter of ...
WuXi PharmaTech Provides Update of 2010 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
SHANGHAI, Jan. 10, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, today announced that it will present at the 29th Annual J.P. Morgan Healt...
WuXi PharmaTech Presents 2010 Life Science and Chemistry Awards
SHANGHAI, Dec. 13, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, today announced the winners of its fourth annual Life Science and Chemist...
WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
SHANGHAI, Nov. 12, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on November 10, 2010. At the meeting, WuXi PharmaTech shareholders approved the re-election of incu...
WuXi PharmaTech Announces Third-Quarter 2010 Results
SHANGHAI, Nov. 10, 2010 / PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial resul...
WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call
SHANGHAI, Oct. 25 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter of 2010...
WuXi PharmaTech Congratulates the 2010 Nobel Laureates in Chemistry
SHANGHAI, Oct. 11 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today extended its congratulations to Dr. Richard Heck, Dr. Ei-ichi Negishi, and ...
Professor Steven V. Ley Speaks at WuXi PharmaTech
SHANGHAI, Oct. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that Dr. Steven V. Ley, BP Professor of Chemistry at the ...
WuXi PharmaTech Awarded GLP Certificate from OECD for Suzhou Toxicology Facility
SHANGHAI, Sept. 20 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it had been awarded a Certificate of Good Laboratory Pr...
WuXi PharmaTech Appoints Edward Hu as Chief Financial Officer
SHANGHAI, Aug. 12 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced the appointment of Edward Hu as Chief Financial Officer effec...
WuXi PharmaTech Announces Second-Quarter 2010 Results
SHANGHAI, Aug. 2 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results f...
WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
SHANGHAI, July 31 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 201...
WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
(Photo: http://www.prnasia.com/sa/200809231435.jpg ) SHANGHAI, July 30 /PRNewswire-Asia-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) announced today that its previously announced transaction with Charles River Laboratories International Inc. (NYSE: CRL) has been terminated by mutua...
ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River
(Photo_out: http://www.prnasia.com/sa/200809231435.jpg ) SHANGHAI, July 28 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that RiskMetrics Group's ISS Proxy Advisory Services ("ISS"), a leading independent proxy voting and corporate governance advisory firm, ha...
WuXi PharmaTech Announces Preliminary Second-Quarter 2010 Financial Highlights and Increases Full-Year 2010 Financial Guidance
SHANGHAI, July 15 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its preliminary financ...
WuXi PharmaTech Schedules Shareholder Meeting for Transaction with Charles River Laboratories
SHANGHAI, June 24 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that the Grand Court of the Cayman Islands has scheduled a hearing for June 29, 2010 in connection with WuXi's proposed cash-and-stock transaction with Charles River Laboratories International, Inc. (...
Professor Eric N. Jacobsen Speaks at WuXi AppTec
SHANGHAI, May 13 /PRNewswire-Asia/ -- WuXi AppTec (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is honored to have Prof. Eric N. Jacobsen, who is the Sheldon Emery Professor of C...
WuXi PharmaTech Announces First-Quarter 2010 Results
SHANGHAI, China, May 12 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...
WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
SHANGHAI, May 12 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX) today announced that it has appointed Hao Zhou as Chief Financial Officer, effective immediately. (Logo: http://www.prnasia.com/sa/2009/04/01/200904011147.jpg ) Mr. Zhou joined the company in May 2009 as Vice Presid...
